Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | A fresh approach to developing chronic pain therapeuticsCellectricon will present a novel phenotypic assay at World Pharma Congress 2013, Tues 4th June, 5pm
By: Cellectricon This exciting new assay is based on the Cellaxess® technology platform, and uses electric field stimulation of primary DRG neuronal cultures to allow compound identification during early stages of the project lifecycle. As such, Dr Karila will explain how the approach can add significant value to the overall decision-making process of drug development, saving valuable time and cost. Dr Paul Karila is Chairperson for the ‘Targeting Pain with Novel Therapeutics’ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|